Viewing Study NCT05917860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-02-03 @ 9:59 AM
Study NCT ID: NCT05917860
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-17
First Post: 2023-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer
Sponsor: Turku University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Localized Prostate Carcinoma View
None Castration-Naive Prostate Cancer View
None Intermediate Risk Prostate Cancer View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MRI-guided transurethral ultrasound ablation View
None Androgen deprivation therapy View
None Neoadjuvant androgen deprivation therapy View
None TULSA View
None Prostate cancer View
None Thermal ablation View
None Therapeutic ultrasound View
None Ablation therapy View